Product Name: Plk3 (357-374)
Product Number: PE-01BFA75
| Size: | 200 µg | Price: | 14.00 | |
| 1 mg | $US | 27.00 | ||
| 5 mg | 74.00 |
Peptide Name: Plk3 (357-374)
Product Use: Services as a blocking peptide for use with the Plk3-AKCD rabbit polyclonal antibody (Cat. No.: AB-NK147-2) that is also available from Kinexus. The peptide sequence is located after the kinase catalytic domain.
Peptide Production Method: Solid-phase peptide synthesis
Peptide Origin: Homo sapiens
Peptide Sequence: KSKNHAQERDEVSGLVSGC
Peptide Modifications N Terminus: Free amino
Peptide Modifications C Terminus: Amide
Peptide Molecular Mass Calculated: 2043.2 Da
Peptide Purity Percent after Synthesis and Purification: >50
Product Use: Services as a blocking peptide for use with the Plk3-AKCD rabbit polyclonal antibody (Cat. No.: AB-NK147-2) that is also available from Kinexus. The peptide sequence is located after the kinase catalytic domain.
Peptide Production Method: Solid-phase peptide synthesis
Peptide Origin: Homo sapiens
Peptide Sequence: KSKNHAQERDEVSGLVSGC
Peptide Modifications N Terminus: Free amino
Peptide Modifications C Terminus: Amide
Peptide Molecular Mass Calculated: 2043.2 Da
Peptide Purity Percent after Synthesis and Purification: >50
Peptide Appearance: White powder
Peptide Form: Solid
Storage Conditions: -20°C
Related Product 1: Plk3 pan-specific antibody (Cat. No.: AB-NK147-2)
Peptide Form: Solid
Storage Conditions: -20°C
Related Product 1: Plk3 pan-specific antibody (Cat. No.: AB-NK147-2)
Scientific Background: Plk3 (CNK) is a protein-serine/threonine kinase of the Other group and Plk family. It plays a role in cell cycle regulation and tumourigenesis. Overexpression of Plk3 leads to mitotic arrest, cytokinesis defects, and apoptosis. Polymorphisms of Plk3 gene have been identified in human lung carcinoma cell lines.
© Kinexus Bioinformatics Corporation 2017